vs

Side-by-side financial comparison of AMERICAN AXLE & MANUFACTURING HOLDINGS INC (AXL) and CABOT CORP (CBT). Click either name above to swap in a different company.

AMERICAN AXLE & MANUFACTURING HOLDINGS INC is the larger business by last-quarter revenue ($1.4B vs $849.0M, roughly 1.6× CABOT CORP). CABOT CORP runs the higher net margin — 8.6% vs -5.4%, a 14.0% gap on every dollar of revenue. On growth, AMERICAN AXLE & MANUFACTURING HOLDINGS INC posted the faster year-over-year revenue change (0.2% vs -11.1%). CABOT CORP produced more free cash flow last quarter ($57.0M vs $54.7M). Over the past eight quarters, AMERICAN AXLE & MANUFACTURING HOLDINGS INC's revenue compounded faster (-7.2% CAGR vs -8.7%).

American Axle & Manufacturing, Inc. (AAM), headquartered in Detroit, Michigan, is an American manufacturer of automobile driveline and drivetrain components and systems.

Cabot Corporation is an American specialty chemicals and performance materials company headquartered in Boston, Massachusetts. The company operates in over 20 countries with 36 manufacturing plants, eight research and development facilities, and 28 sales offices.

AXL vs CBT — Head-to-Head

Bigger by revenue
AXL
AXL
1.6× larger
AXL
$1.4B
$849.0M
CBT
Growing faster (revenue YoY)
AXL
AXL
+11.3% gap
AXL
0.2%
-11.1%
CBT
Higher net margin
CBT
CBT
14.0% more per $
CBT
8.6%
-5.4%
AXL
More free cash flow
CBT
CBT
$2.3M more FCF
CBT
$57.0M
$54.7M
AXL
Faster 2-yr revenue CAGR
AXL
AXL
Annualised
AXL
-7.2%
-8.7%
CBT

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
AXL
AXL
CBT
CBT
Revenue
$1.4B
$849.0M
Net Profit
$-75.3M
$73.0M
Gross Margin
10.2%
24.9%
Operating Margin
-2.4%
15.2%
Net Margin
-5.4%
8.6%
Revenue YoY
0.2%
-11.1%
Net Profit YoY
-449.6%
-21.5%
EPS (diluted)
$-0.62
$1.37

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AXL
AXL
CBT
CBT
Q4 25
$1.4B
$849.0M
Q3 25
$1.5B
$899.0M
Q2 25
$1.5B
$923.0M
Q1 25
$1.4B
$936.0M
Q4 24
$1.4B
$955.0M
Q3 24
$1.5B
$1.0B
Q2 24
$1.6B
$1.0B
Q1 24
$1.6B
$1.0B
Net Profit
AXL
AXL
CBT
CBT
Q4 25
$-75.3M
$73.0M
Q3 25
$9.2M
$43.0M
Q2 25
$39.3M
$101.0M
Q1 25
$7.1M
$94.0M
Q4 24
$-13.7M
$93.0M
Q3 24
$10.0M
$137.0M
Q2 24
$18.2M
$109.0M
Q1 24
$20.5M
$84.0M
Gross Margin
AXL
AXL
CBT
CBT
Q4 25
10.2%
24.9%
Q3 25
12.6%
24.5%
Q2 25
13.1%
26.4%
Q1 25
12.3%
25.7%
Q4 24
11.2%
24.6%
Q3 24
11.4%
24.0%
Q2 24
13.3%
25.2%
Q1 24
12.4%
24.1%
Operating Margin
AXL
AXL
CBT
CBT
Q4 25
-2.4%
15.2%
Q3 25
3.2%
15.2%
Q2 25
3.6%
18.1%
Q1 25
3.0%
17.3%
Q4 24
2.6%
16.2%
Q3 24
2.8%
15.0%
Q2 24
5.3%
16.9%
Q1 24
4.8%
15.3%
Net Margin
AXL
AXL
CBT
CBT
Q4 25
-5.4%
8.6%
Q3 25
0.6%
4.8%
Q2 25
2.6%
10.9%
Q1 25
0.5%
10.0%
Q4 24
-1.0%
9.7%
Q3 24
0.7%
13.7%
Q2 24
1.1%
10.7%
Q1 24
1.3%
8.2%
EPS (diluted)
AXL
AXL
CBT
CBT
Q4 25
$-0.62
$1.37
Q3 25
$0.07
$0.80
Q2 25
$0.32
$1.86
Q1 25
$0.06
$1.69
Q4 24
$-0.11
$1.67
Q3 24
$0.08
$2.41
Q2 24
$0.15
$1.94
Q1 24
$0.17
$1.49

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AXL
AXL
CBT
CBT
Cash + ST InvestmentsLiquidity on hand
$708.9M
$230.0M
Total DebtLower is stronger
$4.0B
Stockholders' EquityBook value
$640.0M
$1.6B
Total Assets
$6.7B
$3.8B
Debt / EquityLower = less leverage
6.31×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AXL
AXL
CBT
CBT
Q4 25
$708.9M
$230.0M
Q3 25
$714.1M
$258.0M
Q2 25
$586.5M
$239.0M
Q1 25
$549.2M
$213.0M
Q4 24
$552.9M
$183.0M
Q3 24
$542.5M
$223.0M
Q2 24
$519.9M
$197.0M
Q1 24
$469.8M
$206.0M
Total Debt
AXL
AXL
CBT
CBT
Q4 25
$4.0B
Q3 25
$2.6B
$1.1B
Q2 25
$2.6B
Q1 25
$2.6B
Q4 24
$2.6B
Q3 24
$2.6B
$1.1B
Q2 24
$2.7B
Q1 24
$2.7B
Stockholders' Equity
AXL
AXL
CBT
CBT
Q4 25
$640.0M
$1.6B
Q3 25
$718.4M
$1.6B
Q2 25
$673.0M
$1.5B
Q1 25
$596.3M
$1.4B
Q4 24
$562.8M
$1.4B
Q3 24
$616.3M
$1.4B
Q2 24
$609.6M
$1.3B
Q1 24
$621.4M
$1.4B
Total Assets
AXL
AXL
CBT
CBT
Q4 25
$6.7B
$3.8B
Q3 25
$5.3B
$3.8B
Q2 25
$5.3B
$3.8B
Q1 25
$5.1B
$3.8B
Q4 24
$5.1B
$3.6B
Q3 24
$5.3B
$3.7B
Q2 24
$5.3B
$3.6B
Q1 24
$5.4B
$3.6B
Debt / Equity
AXL
AXL
CBT
CBT
Q4 25
6.31×
Q3 25
3.61×
0.70×
Q2 25
3.86×
Q1 25
4.38×
Q4 24
4.58×
Q3 24
4.28×
0.75×
Q2 24
4.42×
Q1 24
4.40×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AXL
AXL
CBT
CBT
Operating Cash FlowLast quarter
$120.5M
$126.0M
Free Cash FlowOCF − Capex
$54.7M
$57.0M
FCF MarginFCF / Revenue
4.0%
6.7%
Capex IntensityCapex / Revenue
4.8%
8.1%
Cash ConversionOCF / Net Profit
1.73×
TTM Free Cash FlowTrailing 4 quarters
$155.1M
$401.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AXL
AXL
CBT
CBT
Q4 25
$120.5M
$126.0M
Q3 25
$143.3M
$219.0M
Q2 25
$91.9M
$249.0M
Q1 25
$55.9M
$73.0M
Q4 24
$151.2M
$124.0M
Q3 24
$143.6M
$204.0M
Q2 24
$142.8M
$207.0M
Q1 24
$17.8M
$176.0M
Free Cash Flow
AXL
AXL
CBT
CBT
Q4 25
$54.7M
$57.0M
Q3 25
$79.2M
$155.0M
Q2 25
$34.6M
$188.0M
Q1 25
$-13.4M
$1.0M
Q4 24
$73.2M
$47.0M
Q3 24
$70.4M
$112.0M
Q2 24
$94.0M
$155.0M
Q1 24
$-30.2M
$133.0M
FCF Margin
AXL
AXL
CBT
CBT
Q4 25
4.0%
6.7%
Q3 25
5.3%
17.2%
Q2 25
2.3%
20.4%
Q1 25
-0.9%
0.1%
Q4 24
5.3%
4.9%
Q3 24
4.7%
11.2%
Q2 24
5.8%
15.3%
Q1 24
-1.9%
13.1%
Capex Intensity
AXL
AXL
CBT
CBT
Q4 25
4.8%
8.1%
Q3 25
4.3%
7.1%
Q2 25
3.7%
6.6%
Q1 25
4.9%
7.7%
Q4 24
5.6%
8.1%
Q3 24
4.9%
9.2%
Q2 24
3.0%
5.1%
Q1 24
3.0%
4.2%
Cash Conversion
AXL
AXL
CBT
CBT
Q4 25
1.73×
Q3 25
15.58×
5.09×
Q2 25
2.34×
2.47×
Q1 25
7.87×
0.78×
Q4 24
1.33×
Q3 24
14.36×
1.49×
Q2 24
7.85×
1.90×
Q1 24
0.87×
2.10×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AXL
AXL

Driveline$748.4M54%
Other$345.7M25%
Metal Forming$289.8M21%

CBT
CBT

Reinforcement Materials$520.0M61%
Performance Chemicals$300.0M35%
Shipping And Handling$25.0M3%
Other Products And Services$4.0M0%

Related Comparisons